Alemtuzumab (CAMPATH) not yet approved for MS
- Details
- Category: Medications
- Written by R. Adam Quigley
- Hits: 1794
* immunosuppressive medication - powerful
* rarely used as therapy at first due to their increased risk
* risk of automimmune complications
* bleeding (ITP) in 2-3 %
* thyroid dysfunction in about 20%
* appears more powerful than interferon-beta



Ultrahigh-field strength, T1-weighted magnetization-prepared rapid acquisition and multiple gradient echoes (MPRAGE) is highly sensitive for detecting multiple sclerosis (MS) plaques within the white and gray brain parenchyma, according to a study published online Feb. 20 in Archives of Neurology, one of the JAMA/Archives...
Cannabis-based medicinal products, such as Sativex, could soon be available to sufferers of Multiple Sclerosis (MS) and other medical conditions on prescription.
One in a lakh Indians is thought to suffer from multiple sclerosis, a life-long disorder of the nervous system. Support groups are lobbying to bring the disease under the Disability Act, and are fighting for insurance cover.



